0001140361-23-053522.txt : 20231116 0001140361-23-053522.hdr.sgml : 20231116 20231115200236 ACCESSION NUMBER: 0001140361-23-053522 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231114 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 231412144 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 8-K 1 ef20014806_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 14, 2023

AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)

Delaware
  
000-50761
  
11-3146460
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)

14 Plaza Drive Latham, New York
   12110
(Address of Principal Executive Offices)
   (Zip Code)

(518) 795-1400
(Registrant’s telephone number, including area code)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on which registered
Common Stock, par value $0.01 per share
  
ANGO
  
NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)          As described below, the shareholders of AngioDynamics, Inc. (“AngioDynamics”) voted on November 14, 2023 to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan (the “2020 Plan”). The material terms of the 2020 Plan are described in Proposal 4 included in AngioDynamics’ definitive proxy statement filed with the Securities and Exchange Commission on September 28, 2023 (as supplemented, the “Proxy Statement”), which description does not purport to be complete and is qualified in its entirety by reference to the full text of the 2020 Plan, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.07 – Submission of Matters to a Vote of Security Holders.

(a)          The Annual Meeting of Shareholders of AngioDynamics was held on November 14, 2023.

(b)          Shareholders of AngioDynamics voted on the matters set forth below.


 1.
The nominees for election to the Board of Directors of AngioDynamics were elected, each as a Class II director to serve until the 2026 Annual Meeting of Shareholders of AngioDynamics and until their respective successors are duly elected and qualified, based upon the following votes:

Nominee
Votes For
Withheld
Broker Non-Votes
Eileen O. Auen
23,553,074
3,039,968
5,784,837
       
James C. Clemmer
25,883,397
709,645
5,784,837
       
Howard W. Donnelly
24,605,006
1,988,036
5,784,837
       
Jan Stern Reed
24,900,465
1,692,577
5,784,837


2.
The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics’ independent registered public accounting firm for the fiscal year ending May 31, 2024 was approved based upon the following votes:

Votes for approval
32,364,352
Votes against
11,237
Abstentions
2,290
 
There were no broker non-votes for this item.


3.
The proposal to approve, on an advisory basis, AngioDynamics’ executive compensation of its named executive officers (“Say On Pay”) was approved based upon the following votes:

Votes for approval
24,393,365
Votes against
2,193,446
Abstentions
6,231
Broker non-votes
5,784,837


4.
The proposal to approve amendments to  the AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes:

Votes for approval
24,111,357
Votes against
2,461,478
Abstentions
20,207
Broker non-votes
5,784,837


5.
The proposal to approve, on an advisory basis the frequency of the Say On Pay vote was approved to take place annually based upon the following votes:

Votes for 1 year
24,882,516
Votes for 2 years
5,024
Votes for 3 years
1,696,442
Abstentions
9,060
Broker non-votes
5,784,837

(c)          Not applicable.

(d)          AngioDynamics has considered the advisory vote on Say On Pay frequency, and determined that it will hold an advisory vote on executive compensation of its named executive officers every year until the next Say On Pay frequency vote.

Item 9.01 – Financial Statements and Exhibits.

(d)          Exhibits.

 Exhibit No.
  
Description
     
 
AngioDynamics, Inc. 2020 Equity Incentive Plan, as amended (Incorporated by reference to Appendix A of the Registrant’s Definitive Proxy Statement filed on September 28, 2023 in connection with the Annual Meeting held on November 14, 2023 (File No. 000-50761)).

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
ANGIODYNAMICS, INC.
   
(Registrant)
         
Date:  November 15, 2023
By:
/s/ Stephen Trowbridge
     
Name:
Stephen Trowbridge
     
Title:
Executive Vice President, CFO


EX-101.SCH 2 ango-20231114.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 ango-20231114_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 4 ango-20231114_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Nov. 14, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 14, 2023
Entity File Number 000-50761
Entity Registrant Name AngioDynamics, Inc.
Entity Central Index Key 0001275187
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 11-3146460
Entity Address, Address Line One 14 Plaza Drive
Entity Address, City or Town Latham
Entity Address, State or Province NY
Entity Address, Postal Zip Code 12110
City Area Code 518
Local Phone Number 795-1400
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol ANGO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 6 ef20014806_8k_htm.xml IDEA: XBRL DOCUMENT 0001275187 2023-11-14 2023-11-14 false 0001275187 8-K 2023-11-14 AngioDynamics, Inc. DE 000-50761 11-3146460 14 Plaza Drive Latham NY 12110 518 795-1400 false false false false Common Stock, par value $0.01 per share ANGO NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://angiodynamics.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ango-20231114.xsd ango-20231114_lab.xml ango-20231114_pre.xml ef20014806_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20014806_8k.htm": { "nsprefix": "ango", "nsuri": "http://angiodynamics.com/20231114", "dts": { "schema": { "local": [ "ango-20231114.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "ango-20231114_lab.xml" ] }, "presentationLink": { "local": [ "ango-20231114_pre.xml" ] }, "inline": { "local": [ "ef20014806_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://angiodynamics.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20231114to20231114", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20014806_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231114to20231114", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20014806_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://angiodynamics.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0001140361-23-053522-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-053522-xbrl.zip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end